Companies won’t share COVID-19 shots, stalling future vaccine research

nearly $60 million to seven other academic teams working on what’s called pancoronavirus vaccine development, which has similar goals. Four groups receiving support from either CEPI or NIAID toldthat long-existing difficulties obtaining comparator vaccines has slowed their progress. “The acquisition of those direct comparators has been very difficult and challenging,” says In-Kyu Yoon, a CEPI director.

The original doses of the Pfizer and Modern vaccines, which contain the surface protein from the initial strain of SARS-CoV-2, are of limited value as comparators: The two companies now make “bivalent” products that mix in a surface protein from the Omicron variant. But they, too, are locked up under the government purchase agreements.

PrEP4All, a nonprofit that advocates for improved public health responses to the COVID-19 pandemic, in April published

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Michelin Exits Russia After Selling Local Companies To Leading Tire Distributor | CarscoopsRussia had accounted for approximately 2% of Michelin's sales before the start of the war car auto cars
La source: Carscoop - 🏆 306. / 63 Lire la suite »

Russia’s Private Military Companies Expand at the Front as Moscow Seeks More SoldiersSecurity firms created by Russia’s biggest state corporations, former military officers and businessmen sent troops to Ukraine's front lines in a bid to prove loyalty to the Kremlin
La source: WSJ - 🏆 98. / 63 Lire la suite »

6 remote and hybrid companies that help pay for employees' vacations—and are all hiring nowTo stave off burnout and improve employee retention, more companies are offering to help offset the cost of employees’ vacations.
La source: CNBC - 🏆 12. / 72 Lire la suite »